Symptom-centric view

Bone loss

Substances reporting Bone loss disproportionately — ranked by ROR.

Pain Drug ineffective Off label use Fatigue Dyspnoea Acute kidney injury

showing 16 of 16

Substance ↓	ROR [95% CI]	Reports	Category	Label
tenofovir disoproxil fumarate —	935.1 [901.0–970.5]	10,909	algemeen	new
tenofovir alafenamide —	559.4 [540.8–578.7]	7,255	algemeen	new
rilpivirine hydrochloride —	290.1 [275.5–305.4]	1,943	algemeen	new
rilpivirine —	136.5 [130.0–143.5]	1,944	algemeen	new
emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate —	458.0 [431.7–486.0]	1,552	algemeen	new
emtricitabine, rilpivirine hydrochloride, and tenofovir alafenamide —	379.4 [349.3–412.1]	740	algemeen	new
emtricitabine and tenofovir disoproxil fumarate —	952.9 [920.1–986.8]	9,644	algemeen	new
emtricitabine and tenofovir alafenamide —	599.9 [579.7–620.9]	6,795	algemeen	new
emtricitabine —	823.8 [793.8–854.8]	10,888	algemeen	new
elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate —	501.2 [476.0–527.7]	2,141	algemeen	new
elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide —	522.0 [497.0–548.3]	2,417	algemeen	new
darunavir, cobicistat, emtricitabine, and tenofovir alafenamide —	407.2 [371.3–446.5]	599	algemeen	new
darunavir ethanolate and cobicistat —	33.7 [24.8–45.8]	42	algemeen	new
darunavir —	56.3 [52.1–60.7]	716	algemeen	new
cobicistat —	463.5 [445.8–482.0]	4,095	algemeen	new
bictegravir sodium, emtricitabine, and tenofovir alafenamide fumarate —	431.0 [413.5–449.3]	3,448	algemeen	new

ROR = reporting odds ratio vs. the full FAERS corpus. A signal is not a cause. Source: openFDA (FAERS).